Prematurity and the burden of influenza and respiratory syncytial virus disease
- PMID: 26582294
- DOI: 10.1007/s12519-015-0055-x
Prematurity and the burden of influenza and respiratory syncytial virus disease
Abstract
Background: Respiratory morbidity of former preterm infants and especially those with bronchopulmonary dysplasia (BPD) is high during infancy and early childhood.
Data sources: We performed a review based on a literature search including EMBASE, MEDLINE, and CINAHL databases to identify all relevant papers published in the English and German literature on influenza and respiratory syncytial virus infection associated with preterm infant, prematurity, and BPD between 1980 and 2014.
Results: Recurrent respiratory symptoms remain common at preschool age, school age and even into young adulthood. Acute viral respiratory tract infections due to different pathogens cause significant morbidity and necessitate rehospitalizations during the first years of life. Influenza virus infection plays a minor role compared to respiratory syncytial virus (RSV) associated respiratory tract infection during infancy and early childhood. Nevertheless, particular morbidity to both viruses is high.
Conclusions: The particular burden of both viral diseases in preterm infants is dominated by RSV and its associated rehospitalizations during the first two years of life. Prophylactic measures include vaccination against influenza virus of family members and caregivers and active immunization starting at the age of 6 months, and monthly injections of palivizumab during the cold season to avoid severe RSV disease and its sequelae.
Keywords: bronchopulmonary dysplasia; influenza; preterm infant; respiratory infectious disease; respiratory syncytial virus.
Similar articles
-
[Prophylaxis of respiratory syncytial virus (RSV) in preterm infants with/without bronchopulmonary dysplasia: hyperimmune globulin (RSV-IGIV) and palivizumab (MEDI-493)].Klin Padiatr. 1999 Nov-Dec;211(6):450-5. doi: 10.1055/s-2008-1043832. Klin Padiatr. 1999. PMID: 10592925 Review. German.
-
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.Pediatrics. 1998 Sep;102(3 Pt 1):531-7. Pediatrics. 1998. PMID: 9738173 Clinical Trial.
-
Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.Pediatrics. 1995 Apr;95(4):463-7. Pediatrics. 1995. PMID: 7700741 Clinical Trial.
-
Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention.Expert Rev Respir Med. 2015;9(6):779-99. doi: 10.1586/17476348.2015.1098536. Epub 2015 Oct 12. Expert Rev Respir Med. 2015. PMID: 26457970 Review.
-
Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria.Pediatr Infect Dis J. 2012 Jan;31(1):e1-8. doi: 10.1097/INF.0b013e318235455b. Pediatr Infect Dis J. 2012. PMID: 21960187
Cited by
-
Early Origins of Chronic Obstructive Pulmonary Disease: Prenatal and Early Life Risk Factors.Int J Environ Res Public Health. 2023 Jan 27;20(3):2294. doi: 10.3390/ijerph20032294. Int J Environ Res Public Health. 2023. PMID: 36767660 Free PMC article. Review.
-
Plasma cell and serum antibody responses to influenza vaccine in preterm and full-term infants.Vaccine. 2017 Sep 12;35(38):5163-5171. doi: 10.1016/j.vaccine.2017.07.115. Epub 2017 Aug 12. Vaccine. 2017. PMID: 28807607 Free PMC article.
-
Prematurity and BPD: what general pediatricians should know.Eur J Pediatr. 2023 Apr;182(4):1505-1516. doi: 10.1007/s00431-022-04797-x. Epub 2023 Feb 10. Eur J Pediatr. 2023. PMID: 36763190 Free PMC article. Review.
-
Molecular Mechanism of Caffeine in Preventing Bronchopulmonary Dysplasia in Premature Infants.Front Pediatr. 2022 Jun 20;10:902437. doi: 10.3389/fped.2022.902437. eCollection 2022. Front Pediatr. 2022. PMID: 35795332 Free PMC article. Review.
-
Respiratory management and outcomes in high-risk preterm infants with development of a population outcome dashboard.Thorax. 2023 Dec;78(12):1215-1222. doi: 10.1136/thorax-2023-220174. Epub 2023 Aug 28. Thorax. 2023. PMID: 37640548 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical